Getinge AB ADR | Income Statement

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
25,287
26,669
30,235
22,170
22,495
24,172
Cost of Goods Sold (COGS) incl. D&A
13,173
14,719
17,436
12,773
12,913
14,011
Gross Income
12,114
11,950
12,799
9,397
9,582
10,161
SG&A Expense
7,850
8,033
9,139
6,738
7,204
8,091
EBIT
4,118
3,917
3,660
-
2,378
2,070
Unusual Expense
414
1,200
800
1,172
763
117
Non Operating Income/Expense
49
98
167
22
121
2,147
Interest Expense
619
649
719
545
572
450
Pretax Income
3,153
1,987
1,997
979
933
624
Income Tax
858
539
540
256
184
315
Consolidated Net Income
2,295
1,448
1,457
723
1,117
939
Net Income
2,285
1,433
1,390
698
1,096
967
Net Income After Extraordinaries
2,285
1,433
1,390
208
816
967
Net Income Available to Common
2,285
1,433
1,390
1,188
1,376
967
EPS (Basic)
9.45
5.92
5.75
4.91
5.49
3.55
Basic Shares Outstanding
242
242
242
242
251
272
EPS (Diluted)
9.45
5.93
5.75
4.91
5.49
3.55
Diluted Shares Outstanding
242
242
242
242
251
272
EBITDA
5,983
6,036
6,113
4,397
4,289
3,761
Other Operating Expense
146
-
-
-
-
-
Non-Operating Interest Income
19
17
23
15
11
20
Minority Interest Expense
10
15
67
25
21
28

About Getinge AB

View Profile
Address
Lindholmspiren 7A
Gothenburg VG 417 56
Sweden
Employees -
Website http://www.getingegroup.com
Updated 07/08/2019
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It operates through the following segments: Acute Care Therapies, Surgical Workflows, and Group Functions. The Acute Care Therapies segment offers solutions for life support in acute health conditions which includes solutions for cardiac, pulmonary and vascular therapies and a broad selection of products and therapies for intensive care.